Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Eberli

Showing results (181-190 of 238) with videos related to

Pageof 24
Sort By:
BMJ Open|April 19, 2022
Prospective observational study of the role of the microbiome in BCG responsiveness prediction (SILENT-EMPIRE): a study protocolUwe Bieri, Michael Scharl, Silvan Sigg, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 13, 2021
What's behind <sup>68</sup>Ga-PSMA-11 uptake in primary prostate cancer PET? Investigation of histopathological parameters and immunohistochemical PSMA expression patternsJan H Rüschoff, Daniela A Ferraro, Urs J Muehlematter, et al.
Biomaterials|January 24, 2013
Hemostatic properties and the role of cell receptor recognition in human hair keratin protein hydrogelsLuke R Burnett, Maria B Rahmany, Jillian R Richter, et al.
Oncology Letters|January 2, 2016
Positive fibroblast growth factor receptor 3 immunoreactivity is associated with low-grade non-invasive urothelial bladder cancerCédric Poyet, Thomas Hermanns, Qing Zhong, et al.
The Journal of Urology|October 26, 2019
External Validation and Comparison of Prostate Cancer Risk Calculators Incorporating Multiparametric Magnetic Resonance Imaging for Prediction of Clinically Significant Prostate CancerKarim Saba, Marian S Wettstein, Laura Lieger, et al.
Insights Into Imaging|April 15, 2022
Quantitative imaging parameters to predict the local staging of prostate cancer in intermediate- to high-risk patientsRiccardo Laudicella, Stephan Skawran, Daniela A Ferraro, et al.
Journal of Endourology|January 8, 2019
Pure Bipolar Plasma Vaporization of the Prostate: Results from a Prospective 3D Ultrasound Volumetry Study with Clinical Outcome After 3 YearsThomas Hermanns, Oliver Gross, Christian D Fankhauser, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 4, 2025
High-Intensity Focused Ultrasound in Prostate Cancer: Can PSMA PET Improve Focal Therapy Outcomes?Alexander Maurer, Urs J Muehlematter, Thibika Sivakumar, et al.
Oncotarget|April 21, 2017
Negative LC3b immunoreactivity in cancer cells is an independent prognostic predictor of prostate cancer specific deathAshkan Mortezavi, Souzan Salemi, Niels J Rupp, et al.
The Journal of Urology|May 2, 2019
Extensive Histological Sampling following Focal Therapy of Clinically Significant Prostate Cancer with High Intensity Focused UltrasoundAshkan Mortezavi, Johanna Krauter, Alexander Gu, et al.
Pageof 24

Showing results (181-190 of 238) with videos related to

Sort By:
Pageof 24
BMJ Open|April 19, 2022
Prospective observational study of the role of the microbiome in BCG responsiveness prediction (SILENT-EMPIRE): a study protocolUwe Bieri, Michael Scharl, Silvan Sigg, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 13, 2021
What's behind <sup>68</sup>Ga-PSMA-11 uptake in primary prostate cancer PET? Investigation of histopathological parameters and immunohistochemical PSMA expression patternsJan H Rüschoff, Daniela A Ferraro, Urs J Muehlematter, et al.
Biomaterials|January 24, 2013
Hemostatic properties and the role of cell receptor recognition in human hair keratin protein hydrogelsLuke R Burnett, Maria B Rahmany, Jillian R Richter, et al.
Oncology Letters|January 2, 2016
Positive fibroblast growth factor receptor 3 immunoreactivity is associated with low-grade non-invasive urothelial bladder cancerCédric Poyet, Thomas Hermanns, Qing Zhong, et al.
The Journal of Urology|October 26, 2019
External Validation and Comparison of Prostate Cancer Risk Calculators Incorporating Multiparametric Magnetic Resonance Imaging for Prediction of Clinically Significant Prostate CancerKarim Saba, Marian S Wettstein, Laura Lieger, et al.
Insights Into Imaging|April 15, 2022
Quantitative imaging parameters to predict the local staging of prostate cancer in intermediate- to high-risk patientsRiccardo Laudicella, Stephan Skawran, Daniela A Ferraro, et al.
Journal of Endourology|January 8, 2019
Pure Bipolar Plasma Vaporization of the Prostate: Results from a Prospective 3D Ultrasound Volumetry Study with Clinical Outcome After 3 YearsThomas Hermanns, Oliver Gross, Christian D Fankhauser, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 4, 2025
High-Intensity Focused Ultrasound in Prostate Cancer: Can PSMA PET Improve Focal Therapy Outcomes?Alexander Maurer, Urs J Muehlematter, Thibika Sivakumar, et al.
Oncotarget|April 21, 2017
Negative LC3b immunoreactivity in cancer cells is an independent prognostic predictor of prostate cancer specific deathAshkan Mortezavi, Souzan Salemi, Niels J Rupp, et al.
The Journal of Urology|May 2, 2019
Extensive Histological Sampling following Focal Therapy of Clinically Significant Prostate Cancer with High Intensity Focused UltrasoundAshkan Mortezavi, Johanna Krauter, Alexander Gu, et al.
Pageof 24